The Role of IO Based Therapy in Patients with HCC: An All Stage Strategy?

Faculty: Tanios S. Bekaii-Saab, MD
Disclosures

Downloadable Slides

Faculty

Speaker

Tanios S. Bekaii-Saab, MD
David F. and Margaret T. Grohne Professsor of Novel Therapeutics for Cancer Research
Chair and Consultant, Division of Hematology and Medical Oncology
Professor, Mayo Clinic College of Medicine and Science
Mayo Clinic in Arizona

Discover more from OmniOncology.net

Subscribe now to keep reading and get access to the full archive.

Continue reading